Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Journal of Medical Virology|June 30, 2023
Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohortParham Sendi, Nadja Widmer, Mattia Branca, et al.
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Clinical Chemistry and Laboratory Medicine|December 10, 2017
Association of adrenal hormone metabolites and mortality over a 6-year follow-up in COPD patients with acute exacerbationSeline Zurfluh, Manuela Nickler, Manuel Ottiger, et al.
Respiratory Research|December 6, 2018
Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up studySeline Zurfluh, Manuela Nickler, Manuel Ottiger, et al.
BMC Infectious Diseases|August 26, 2018
Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumoniaThomas Baumgartner, Giedré Zurauskaité, Yannick Wirz, et al.
Respiratory Research|January 25, 2017
Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumoniaAlaadin Vögeli, Manuel Ottiger, Marc A Meier, et al.
Frontiers in Immunology|November 15, 2023
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trialPascal Urwyler, Marina Leimbacher, Panteleimon Charitos, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2020
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma ConcentrationsCatia Marzolini, Felix Stader, Marcel Stoeckle, et al.
International Journal of Cardiology|July 10, 2014
Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trialPhilipp Schuetz, Alexander Kutz, Eva Grolimund, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 17, 2026
Lineage-encoded genomic determinants of neonatal invasive Group B Streptococcal diseaseVerena Vogel, Denho Ravi, Christian W Thorball, et al.
Pageof 20